Literature DB >> 29045344

Atrial fibrillation and cardiac resynchronization therapy.

Maurizio Gasparini1, Paola Galimberti.   

Abstract

PURPOSE OF REVIEW: Atrial fibrillation and heart failure are commonly encountered in current clinical practice. This review aims to revisit the complex interaction of these two common situations and the best treatment whenever both occurs, especially focusing on heart failure patients undergoing cardiac resynchronization therapy (CRT). RECENT
FINDINGS: It has been recently confirmed that in patients undergoing cardiac resynchronization therapy, 100% biventricular pacing percentage should be pursued. Large observational studies confirmed that atrioventricular junction ablation is very often the only way to gain 100% biventricular pacing in atrial fibrillation.
SUMMARY: On the basis of the recent observational extensive data, in patients presenting intermediate or elevated atrial tachycardia-atrial fibrillation burden, atrioventricular junction ablation may represent a fundamental tool to achieve full CRT delivery, thus, conferring marked improvements in global cardiac function, and by extension, in survival. Atrial fibrillation patients should not be excluded from CRT, provided that maximal biventricular pacing is warranted.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29045344     DOI: 10.1097/HCO.0000000000000472

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  3 in total

1.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30

2.  A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy.

Authors:  Minsi Cai; Wei Hua; Nixiao Zhang; Shengwen Yang; Yiran Hu; Min Gu; Hongxia Niu; Shu Zhang
Journal:  BMC Cardiovasc Disord       Date:  2020-05-13       Impact factor: 2.298

3.  Cardiac resynchronization therapy in the presence of total atrioventricular block reduces long-lasting atrial fibrillation episodes.

Authors:  Lara Kugler; Susanne Markendorf; Marta Bachmann; Urs Eriksson
Journal:  J Arrhythm       Date:  2022-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.